S5 Fig -

<p><b>(A)</b> Schematic representation of GiMlf-His protein and its truncated forms with the indicated Mlf1IP domain, secondary structure, and positions of truncation of the individual forms. NT–N-terminal domain, CT–C- terminal domain. <b>(B)</b> SDS-electrophoresis of purified recombinant proteins stained with Coomassie stain. <b>(C)</b>. His peptide was used as a negative control for the incubation with the lipid strip, the peptide was detected by an anti-His antibody, TG–triglyceride, DAG–diacylglycerol, PA–phosphatidic acid, PS–phosphatidylserine, PE–phosphatidylethanolamine, PC–phosphatidylcholine, PG–phosphatidylglycerol, CL–cardiolipin, PI–phosphatidylinositol, C–cholesterol, SM–sphingomyelin, 3-SGC– 3-sulfogalactosylceramide, PI(4)P–phosphatidylinositol (4)-phosphate, PI(4,5)P<sub>2</sub> –phosphatidylinositol (4,5)-bisphosphate, PI(3,4,5)P<sub>3</sub> –phosphatidylinositol (3,4,5)-trisphosphate.</p> <p>(PDF)</p>